Reversal of glycogen storage disease type IIIa-related cardiomyopathy with modification of diet

Journal of Inherited Metabolic Disease

Volumn 32, Issue SUPPL. 1, 2009, Pages

  Dagli, A I ^a   Zori, R T ^a   McCune, H ^a   Ivsic, T ^a   Maisenbacher, M K ^a   Weinein, D A ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STARCH;

ADULT; ARTICLE; CARDIOMYOPATHY; CASE REPORT; DIET THERAPY; GLYCOGEN STORAGE DISEASE TYPE 3; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; LIVER; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PROTEIN INTAKE;

CARDIOMYOPATHIES; DIETARY PROTEINS; GLYCOGEN STORAGE DISEASE TYPE III; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; LIVER; MALE; STARCH; YOUNG ADULT;

EID: 84881082620     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-009-1088-x     Document Type: Article

References (22)

1. Akazawa H, Kuroda T, Kim S, Mito H, Kojo T, Shimada K (1997) Specific heart muscle disease associated with glycogen storage disease type III: clinical similarity to the dilated phase of hypertrophic cardiomyopathy. Eur Heart J 18: 532-533. (Pubitemid 27110494)
2. Bao Y, Yang BZ, Dawson TL Jr, Chen YT (1997) Isolation and nucleotide sequence of human liver glycogen debranching enzyme mRNA: identification of multiple tissue-specific isoforms. Gene 197: 389-398. doi:10.1016/S0378-1119(97) 00291-6. (Pubitemid 27399917)
3. Bates EJ, Heaton GM, Taylor C, Kernohan JC, Cohen P (1975) Debranching enzyme from rabbit skeletal muscle; evidence for the location of two active centres on a single polypeptide chain. FEBS Lett 58 : 181-185. doi:10.1016/0014-5793(75)80254-7.
4. Carvalho JS, Matthews EE, Leonard JV, Deanfield J (1993) Cardiomyopathy of glycogen storage disease type III. Heart Vessels 8: 155-159. doi:10.1007/BF01744800. (Pubitemid 23244689)
5. Chen YT (2001) Glycogen storage diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 1521-1551.
6. Coleman RA, Winter HS, Wolf B, Gilchrist JM, Chen YT (1992) Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy. Ann Intern Med 116: 896-900. (Pubitemid 23034780)
7. DiMauro S, Hartwig GB, Hays A, et al (1979) Debrancher deficiency: neuromuscular disorder in 5 adults. Ann Neurol 5: 422-436. doi:10.1002/ana. 410050504. (Pubitemid 9150134)
8. Fellows IW, Lowe JS, Ogilvie AL, Stevens A, Toghill PJ, Atkinson M (1983) Type III glycogenosis presenting as liver disease in adults with atypical histological features. J Clin Pathol 36: 431-434. doi:10.1136/jcp.36.4.431. (Pubitemid 13163396)
9. Kiechl S, Willeit J, Vogel W, Kohlendorfer U, Poewe W (1999) Reversible severe myopathy of respiratory muscles due to adult-onset type III glycogenosis. Neuromuscul Disord 9: 408-410. doi:10.1016/S0960-8966(99)00038-3. (Pubitemid 29454602)
10. Labrune P, Huguet P, Odievre M (1991) Cardiomyopathy in glycogen-storage disease type III: clinical and echographic study of 18 patients. Pediatr Cardiol 12 : 161-163. doi:10.1007/BF02238523.
11. Lee PJ, Deanfield JE, Burch M, Baig K, McKenna WJ, Leonard JV (1997) Comparison of the functional significance of left ventricular hypertrophy in hypertrophic cardiomyopathy and glycogenosis type III. Am J Cardiol 79 : 834-838. doi:10.1016/S0002-9149(96)00885-5. (Pubitemid 27152354)
12. Liu W, Madsen NB, Braun C, Withers SG (1991) Reassessment of the catalytic mechanism of glycogen debranching enzyme. Biochemistry 30: 1419-1424. doi:10.1021/bi00219a036.
13. Miller CG, Alleyne GA, Brooks SE (1972) Gross cardiac involvement in glycogen storage disease type 3. Br Heart J 34: 862-864. doi:10.1136/hrt.34.8. 862.
14. Momoi T, Sano H, Yamanaka C, Sasaki H, Mikawa H (1992) Glycogen storage disease type III with muscle involvement: reappraisal of phenotypic variability and prognosis. Am J Med Genet 42: 696-699. doi:10.1002/ajmg.1320420514.
15. Moses SW, Wanderman KL, Myroz A, Frydman M (1989) Cardiac involvement in glycogen storage disease type III. Eur J Pediatr 148: 764-766. doi:10.1007/BF00443106. (Pubitemid 19186740)
16. Olson LJ, Reeder GS, Noller KL, Edwards WD, Howell RR, Michels VV (1984) Cardiac involvement in glycogen storage disease III: morphologic and biochemical characterization with endomyocardial biopsy. Am J Cardiol 53: 980-981. doi:10.1016/0002-9149(84)90551-4. (Pubitemid 14162951)
17. Rossignol AM, Meyer M, Rossignol B, Palcoux MP, Raynaud EJ, Bost M (1979) Glycogenosis type III myocardiopathy. Arch Fr Pediatr 36: 303-309.
18. Shen J, Bao Y, Liu HM, Lee P, Leonard JV, Chen YT (1996) Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle. J Clin Invest 98: 352-357. doi:10.1172/JCI118799. (Pubitemid 26255733)
19. Slonim AE, Weisberg C, Benke P, Evans OB, Burr IM (1982) Reversal of debrancher deficiency myopathy by the use of high-protein nutrition. Ann Neurol 11: 420-422. doi:10.1002/ana.410110417. (Pubitemid 12133703)
20. Slonim AE, Coleman RA, Moses WS (1984) Myopathy and growth failure in debrancher deficiency: improvement with high-protein nocturnal enteral therapy. J Pediatr 105: 906-911. doi:10.1016/S0022-3476(84)80075-X. (Pubitemid 15185316)
21. Talente GM, Coleman RA, Alter C, et al (1994) Glycogen storage disease in adults. Ann Intern Med 120: 218-226. (Pubitemid 24038807)
22. Wolfsdorf JI, Weinstein DA (2003) Glycogen storage diseases. Rev Endocr Metab Disord 4 : 95-102. doi:10.1023/A:1021831621210. (Pubitemid 36182154)